Oryzon Genomics
Head of the Cellular Therapy Unit, Co-director of the Haematology and Haemotherapy Unit, and Haematology and Oncology Specialist of the Clinica Universidad de Navarra (Spain). Doctor of Medicine from the University of Navarra. He completed his training with a fellowship in Haematology and Oncology at the University of Minnesota (US).
His research is focused on two main areas: the epigenetic regulation of malignancies (leukemias and myeloma) and cell therapy with adult stem cells and its application to human diseases such as cardiovascular and autoimmune diseases.
Moreover, he is also a member of the Medical Advisory Board in the clinical trial of ORY-1001.
This person is not in the org chart
This person is not in any offices
Oryzon Genomics
Oryzon Genomics is a clinical‐stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases.